Valuation: CellaVision AB

Market Cap 3.26B 338M 295M 273M 251M 474M 32.57B 483M 1.28B 15.9B 1.27B 1.24B 54.9B P/E 2026 *
23.9x
P/E 2027 * 19.1x
Enterprise Value 3.04B 316M 276M 255M 234M 443M 30.42B 451M 1.2B 14.85B 1.19B 1.16B 51.28B EV / Sales 2026 *
4x
EV / Sales 2027 * 3.53x
Free-Float
83.08%
Yield 2026 *
2.01%
Yield 2027 * 2.34%
1 day+1.03%
1 week+3.48%
Current month+0.29%
1 month-6.95%
3 months-10.13%
6 months-14.73%
Current year-13.10%
1 week 131.8
Extreme 131.8
139.8
1 month 131.8
Extreme 131.8
148
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 70.5
Extreme 70.5
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
6/12/26 Buy 760 0.0032%
6/9/26 Buy

Founder

33,000 0.1384%
6/9/26 Buy

Director

314 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+3.48%-24.36%-26.08% 335M
-0.16%+12.12%+17.06%-20.73% 17.63B
-3.55%+2.88%+17.43%+95.22% 1.73B
+0.05%+5.74%-34.74%-78.65% 1.24B
-1.19%-7.52%-36.97%+10.18% 1.02B
+1.98%+8.94%-24.06%-50.67% 659M
+2.44%+6.67%-36.74%-54.14% 562M
-0.28%0.00%+39.20%-53.24% 455M
+0.47%+2.25%-53.49%-58.91% 385M
-3.29%+13.25%+43.55% - 341M
Average -0.29%+3.53%-9.31%-26.34% 2.44B
Weighted average by Cap. -0.54%+9.34%+8.92%-16.95%

Financials

2026 *2027 *
Net sales 760M 78.86M 68.93M 63.75M 58.5M 111M 7.6B 113M 299M 3.71B 296M 290M 12.81B 851M 88.23M 77.12M 71.32M 65.45M 124M 8.5B 126M 334M 4.15B 331M 324M 14.33B
Net income 136M 14.15M 12.37M 11.44M 10.49M 19.86M 1.36B 20.2M 53.57M 666M 53.12M 51.96M 2.3B 175M 18.15M 15.87M 14.67M 13.47M 25.48M 1.75B 25.93M 68.75M 854M 68.17M 66.67M 2.95B
Net Debt -215M -22.32M -19.51M -18.04M -16.55M -31.33M -2.15B -31.88M -84.52M -1.05B -83.81M -81.97M -3.63B -254M -26.33M -23.02M -21.29M -19.53M -36.97M -2.54B -37.61M -99.72M -1.24B -98.89M -96.71M -4.28B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
26-07-16 SEK 136.60 +0.89% 12,521
26-07-15 SEK 135.40 +0.74% 25,981
26-07-14 SEK 134.40 -2.89% 32,098
26-07-13 SEK 138.40 0.00% 21,004
26-07-10 SEK 138.40 +2.67% 12,538
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
135.40SEK
Average target price
171.25SEK
Spread / Average Target
+26.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock